carbostyril has been researched along with Candidiasis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Li, S; Li, Z; Lu, L; Ma, S; Nie, W; Shan, C; Shu, C; Wang, H | 1 |
| Cullen, M; Heward, E; Hobson, J | 1 |
| Fang, H; Gao, P; Jiang, X; Qiao, J | 1 |
| Boerman, OC; Dierckx, R; Rennen, HJ; Siaens, RH; Slegers, G | 1 |
| Kitamura, A; Nakajima, R; Sato, K; Someya, K; Tanaka, M | 1 |
| Allocco, A; Carlone, NA; Cuffini, AM; De Leo, C; Paizis, G; Tullio, V | 1 |
| Hirasaki, S; Koide, N; Ogawa, H; Tsuji, T | 1 |
1 review(s) available for carbostyril and Candidiasis
| Article | Year |
|---|---|
Benign gastric ulcer associated with Canidida infection in a healthy adult.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alanine; Anti-Infective Agents; Anti-Ulcer Agents; Candidiasis; Carnosine; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds; Quinolones; Stomach Ulcer; Zinc; Zinc Compounds | 1999 |
6 other study(ies) available for carbostyril and Candidiasis
| Article | Year |
|---|---|
Whole transcriptome analysis of schinifoline treatment in Caenorhabditis elegans infected with Candida albicans.
Topics: Animals; Antifungal Agents; Caenorhabditis elegans; Candida albicans; Candidiasis; Disease Models, Animal; Drugs, Chinese Herbal; Fungal Proteins; Gene Expression; Gene Expression Profiling; Humans; Lysosomes; Phosphorylation; Proteins; Quinolones; Wnt Signaling Pathway | 2021 |
Microbiology and antimicrobial susceptibility of otitis externa: a changing pattern of antimicrobial resistance.
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Candida; Candidiasis; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Otitis Externa; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 2018 |
In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Microbial Sensitivity Tests; Polyenes; Polyunsaturated Alkamides; Quinolones | 2013 |
Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin.
Topics: Animals; Candida albicans; Candidiasis; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Organotechnetium Compounds; Quinolones; Radionuclide Imaging; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Technetium; Thigh | 2004 |
In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Female; Fluconazole; Fluoroquinolones; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Quinolones; Spiro Compounds | 1995 |
Effect of rufloxacin upon non-specific immune defences: in-vitro, ex-vivo and in-vivo results.
Topics: Animals; Anti-Infective Agents; Candidiasis; Fluoroquinolones; Humans; Immunity, Cellular; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Macrophages; Male; Mice; Phagocytosis; Quinolones | 1994 |